How effective is Duetact for Diabetes? (a real world drug study)

Summary:

Overall ratings: 4.3/5
Long term ratings: 3.5/5

This is a phase IV clinical study of how effective Duetact (glimepiride; pioglitazone hydrochloride) is for Diabetes and for what kind of people. The study is created by eHealthMe from 4 Duetact users and is updated continuously.

What is Duetact?

Duetact has active ingredients of glimepiride; pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 107 Duetact users. Check the latest studies of Duetact.

What is Diabetes?

Diabetes is found to be associated with 2,010 drugs and 2,856 conditions by eHealthMe. Check the latest studies of Diabetes.


On Jul, 22, 2026

4 people are studied for taking Duetact in Diabetes

Overall effectiveness (number of people):

Does Duetact work for your Diabetes (overall)?

Long term (1+ years) effectiveness (number of people):

Does Duetact work for your Diabetes (long term)?

Duetact effectiveness for Diabetes (number of people):

Overall:
  • not at all: 0
  • somewhat: 1
  • moderate: 0
  • high: 0
  • very high: 3
Long Term:
  • not at all: 0
  • somewhat: 1
  • moderate: 0
  • high: 0
  • very high: 1

Gender of people who take Duetact for Diabetes *:

  • female: 75 %
  • male: 25 %

Age of people who take Duetact for Diabetes *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 50 %
  • 60+: 25 %

Who find Duetact more effective for Diabetes?

Gender of people who take Duetact for Diabetes *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who take Duetact for Diabetes *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 33.33 %

* Approximation only. Some reports may have incomplete information.

Do you take Duetact?

- You can start a phase IV clinical trial to monitor Duetact safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on glimepiride; pioglitazone hydrochloride (the active ingredients of Duetact) and Duetact (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: